AlphAIAlphAI — Financial news for AI agents
investing.comOCT 92 min read$BAS.DE

Evonik stock jumps on reports BASF may make new offer; Citi discusses numbers

Evonik Industries' shares rose 2.6% after Reuters reported BASF may submit a new takeover offer. BASF's initial offer of €22.15 per share was rejected in September. Citi analysts estimate a potential €25 per share offer could boost BASF's earnings and cash flow by 20% through 2030, but may reduce return on invested capital to 9%.

Original reporting
investing.com
Published Oct 9, 2026, 7:47 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 7:58 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefMergers & acquisitions
Primary signal
$BAS.DE
Neutral
medium confidence
Mentioned
$BAS.DE · $EVKIF
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BAS.DENeutralMed
01

Why it matters

The news could trigger short‑term buying in Evonik and cause market participants to reassess BASF's valuation and balance sheet.

02

Market read

New M&A rumor creates immediate price movement for Evonik and prompts strategic considerations for BASF and the broader chemicals sector.

03

What to watch

Regulatory approval risk and RAG shareholder opposition could delay or block the transaction.

Relevance 8/10Novelty 8/10Timing: pre-market today

Background

The article reports a fresh Reuters scoop that BASF may launch a second takeover bid for Evonik after an earlier rejected offer.

Company-level read

Ticker impact

$BAS.DENeutralMedium confidence
Context

BASF is cited as the possible acquirer in the reported new takeover offer for Evonik.

Expected impact

potential modest downside as investors assess financing and integration risks

Evidence & confidence

The news focuses on Evonik's upside; BASF impact is secondary and uncertain.

Market effects

Sector

Signals possible consolidation in the European specialty chemicals sector.

Regional

May boost German market sentiment if the deal is viewed positively.

Global

Highlights ongoing M&A activity in the chemicals industry, relevant to global investors.

Counterpoint

What could challenge this read

Deal could fall apart, leading to a sell‑off in Evonik if expectations are not met.

Key entities

  • company
    Evonik Industries AG

    German specialty chemicals producer, target of the potential BASF bid.

  • company
    BASF SE

    World's largest chemical producer, potential acquirer of Evonik.

Read at source← All news

Also covered by

1 outlet

Related articles

OCT 9
Med

Why is Evonik Industries stock climbing today?

Evonik Industries AG stock rose nearly 2% to €21.38, hitting a 52-week high of €21.54, amid speculation of a higher bid from BASF. The RAG-Stiftung, Evonik's majority stakeholder, scheduled a meeting to discuss BASF's proposal, valued at roughly €10.3 billion. Analysts upgraded Evonik to 'Hold' with a €20 price target, citing BASF's interest as a price floor. The stock's rise occurred despite a challenging broader market environment.

investing.com2 min
SEP 28
$EVKIFHighAI 9/10

Evonik Industries Reportedly Rejects BASF's Acquisition Offer

Evonik Industries AG (EVKIF.PK) rejected a 10.3 billion euro acquisition offer from BASF SE (BAS.DE) as it was deemed too low. BASF offered 22.15 euros per share, valuing Evonik at 14.2 billion euros. Evonik's market cap is 8.4 billion euros, and its enterprise value is around 12 billion euros. Combined revenues of both companies were 74 billion euros last year. Evonik's shares were down 1.28 percent on the Frankfurt Exchange.

rttnews.com2 min
SEP 25
$BAS.DEHighAI 8/10

M&A market trends: BASF/Evonik, arb spreads, and tokenization deals this week

BASF proposed a takeover of Evonik, reflecting defensive consolidation in Europe's chemical sector. Other notable deals include Aquarian's bid for Brighthouse Financial with a 31.4% spread, Thoma Bravo's offer for Accelerant Holdings, and Merck's potential acquisition of Bio-Techne. Bullish's $4.2B deal for Equiniti highlights tokenization trends. Spreads vary, signaling different risk profiles.

investing.com3 min
SEP 25
HighAI 9/10

Why is Evonik Industries stock surging today?

Evonik Industries' stock surged 8.1% to €19.54 after BASF SE reportedly proposed a merger, aiming to create a €74B European chemicals giant. Evonik's valuation is €12B including debt. The move follows Evonik's recent struggles, including a 52-week low of €12.49. BASF's approach is part of its strategy to streamline operations and focus on higher-margin businesses.

investing.com2 min